Steven Albert Everett, Craig Alan Coburn, Sohrob Daniel Doroodian, Kiana Hope Everett, Matthew Dean Zuck, Michael Victor Zuck. "Clinical genomic and quantitative IHC–driven target identification to enable precision, tumor-selective activation of SynchroLINK T2X antibody-drug conjugates.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e15043